Exagen Inc.

US$5.81As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XGNHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (12.89%)
Div yield —
ROE (113.82%)
Diagnostics & Research
Beta (5Y) 2.24
PE TTM —
TSR TTM (50.21%)
Mkt cap US$140.7M
ROIC (19.16%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.50
11.86%
(95.85%)
Hold 1|7|2|12|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.06
0.07
0.07
27.56%
11.48%
5.54%
15.24%
Revenue$M
13.99
13.88
14.01
14.51
7.43%
8.56%
7.04%
5.14%
Peers (US$140.7M)
Cap (US$)
PE
90.00M
—
Capital
TTM
5Y
10Y
Leveragex
0.667
0.246
0.251
EBIT/Intx
0.726
0.093
0.090
Own earn%
(26.28)
93.86
89.98
Sh yield%
28.17
31.43
33.11
Owners
Insiders/Inst%
14.11
21.99
Short interest%
2.37
SBC / revenue%
2.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
4–10
$1 testx
—
Incr. ROIC%
1